Friday, Jul 24, 2026

"glycaemic-control"

Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

This launch follows Dr Reddy's recent generic semaglutide injection launches in India and Canada, Dr Reddy's Laboratories Ltd (DRL) said in a statement

Latest News

Youth dies by suicide in Khammam’s Chintakani over health issues

58 seconds ago
NIN study finds regular exercise improves metabolism, bone health and gut microbiome

5 mins ago
Government Engineering College Kosgi struggles to attract students for third consecutive year

18 mins ago
Govt orders GitHub to remove Bluetooth-based chat app Bitchat over security concerns: Jack Dorsey

23 mins ago
Road sinks beneath two-year-old BHEL flyover, raising safety concerns among commuters

26 mins ago
Discussion on Mekedatu issue: CM Vijay received official invite from Karnataka, says minister

39 mins ago
Officials shunted out back-to-back in education ministry shake-up amid exam rows

46 mins ago
Hyderabad to host HIPLEX 2026: PET bottle T-shirts, plastic roads to feature in recycling pavilion

39 mins ago